End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.00 CNY | +0.73% |
|
-2.79% | +24.72% |
11:27am | Gan & Lee Pharmaceuticals sees H1 net profit up 100.7-114.1% Y/Y | RE |
07-08 | Gan & Lee Pharmaceuticals' Insulin Aspart Receives Approval in Argentina | CI |
Main competitors
Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|---|---|
+0.73% | -2.79% | -2.36% | +29.96% | +24.72% | +30.27% | +15.67% | -56.67% | - | 4.56B | ||
-0.91% | +2.30% | +0.74% | -0.85% | -13.45% | -17.54% | -15.19% | -13.12% | +175.13% | 77.69B | ||
+0.15% | -0.05% | +5.77% | -5.07% | -23.14% | -48.06% | -10.90% | -14.54% | +7.56% | 57.88B | ||
+0.49% | +1.80% | +1.80% | +1.80% | +7.27% | +28.54% | +24.30% | +38.32% | - | 52.56B | ||
+0.12% | +2.16% | +6.11% | +31.66% | -11.39% | +18.30% | +96.70% | +57.83% | +154.10% | 37.85B | ||
-0.99% | -0.27% | -0.98% | +10.24% | -13.14% | -42.01% | -38.29% | -52.34% | -66.73% | 19.7B | ||
-0.12% | +4.91% | +12.44% | +95.60% | +124.73% | +117.59% | +123.51% | +40.96% | - | 17.93B | ||
+1.07% | +13.69% | +14.93% | +17.48% | +36.83% | +55.41% | +695.31% | +420.16% | +6,752.13% | 16.32B | ||
-0.04% | -.--% | -.--% | -.--% | +57.89% | +84.28% | +129.06% | +426.43% | +299.85% | 14.02B | ||
+1.88% | +0.88% | -1.60% | +16.84% | -0.43% | +13.29% | -15.06% | -36.25% | -36.39% | 13.1B | ||
+0.14% | +7.38% | +15.55% | +21.92% | -21.80% | -71.99% | -81.45% | -49.95% | - | 12.58B | ||
+3.09% | +4.52% | +5.05% | +0.55% | -9.09% | -27.99% | -31.97% | -52.88% | -57.36% | 11.12B | ||
+0.80% | +0.35% | -16.65% | -7.77% | -14.26% | -7.49% | -46.99% | -0.76% | - | 10.57B | ||
-0.49% | -0.63% | -7.62% | +15.00% | -10.65% | +0.64% | +21.72% | +34.79% | +163.57% | 10.25B | ||
+6.84% | +7.54% | +18.01% | +40.09% | +67.86% | +79.22% | +403.39% | +42.91% | - | 8.2B | ||
+5.19% | +7.17% | +9.55% | +53.72% | +24.18% | +17.60% | -33.45% | -57.08% | -38.14% | 7.7B | ||
+1.02% | +4.86% | +22.77% | +121.43% | +307.89% | +293.65% | +305.23% | +103.28% | +200.61% | 7.38B | ||
+0.76% | +1.78% | +2.56% | -11.27% | -23.95% | -23.25% | -73.25% | -69.82% | +203.03% | 6.62B | ||
+0.87% | +0.73% | -1.14% | -0.57% | -4.16% | -8.47% | +14.38% | -23.11% | -64.82% | 6.32B | ||
+0.27% | +1.51% | -1.44% | +4.97% | +2.08% | +14.67% | -54.46% | -77.11% | +94.67% | 5.69B | ||
Average | +0.92% | +1.70% | +4.17% | +21.79% | +25.40% | +25.33% | +71.41% | +33.05% | +556.23% | 19.9B | |
Weighted average by Cap. | +0.32% | +1.99% | +3.82% | +13.65% | +8.22% | +8.20% | +51.66% | +32.43% | +467.04% |
- Stock Market
- Equities
- 603087 Stock
- Sector Gan & Lee Pharmaceuticals.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition